Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

georgejjl Sunday, 12/03/17 06:43:35 PM
Re: None 0
Post #
205815
of 223841
This is what I expect from the Brilacidin-OM trial top line:
less than 14% of patients treated with Brilacidin-OM will have exhibited severe OM, while 70% of patients in the placebo group will have shown severe OM.

Good luck and GOD bless,

George

For the Per Protocol (PP) population, Brilacidin-OM in the aggressive chemotherapy regimen similarly reduced the incidence of SOM by 80.3% as compared with placebo (Brilacidin: 14.3%; placebo: 72.7%; p=0.0249). Treatments appeared well-tolerated with good safety.

Good luck and GOD bless,

George